• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delayed toxicity of 4'-demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) in mice.

作者信息

Avery T L, Roberts D, Price R A

出版信息

Cancer Chemother Rep. 1973 Apr;57(2):165-73.

PMID:4742496
Abstract
摘要

相似文献

1
Delayed toxicity of 4'-demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) in mice.4'-去甲基表鬼臼毒素9-(4,6-O-2-亚噻吩基-β-D-吡喃葡萄糖苷)(NSC-122819；VM-26)对小鼠的迟发性毒性
Cancer Chemother Rep. 1973 Apr;57(2):165-73.
2
Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).L1210白血病对1,3-双(2-氯乙基)-1-亚硝基脲加4'-去甲基表鬼臼毒素-9-(4,6-O-2-亚苄基-β-D-吡喃葡萄糖苷)治疗的反应
Cancer Res. 1981 Oct;41(10):3891-5.
3
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).新型抗肿瘤药物4'-去甲基表鬼臼毒素9-(4,6-O-亚乙基-α-D-吡喃葡萄糖苷)(NSC-141540；VP-16-213)的I期临床试验
Cancer Chemother Rep. 1972 Dec;56(6):769-77.
4
Acute, chronic and terminal toxicity to 4'-demethylepipodophyllotoxin thenylidene glucoside (VM26) in mice.4'-去甲基表鬼臼毒素噻吩亚甲基葡糖苷（VM26）对小鼠的急性、慢性及终末毒性
Cancer Res. 1975 Jul;35(7):1756-60.
5
Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.用4'-去甲基表鬼臼毒素-9-(4,6-O-2-亚噻吩基-β-D-吡喃葡萄糖苷)或1-β-D-阿拉伯呋喃糖基胞嘧啶或两种药物处理后L1210细胞中DNA的沉降。
Cancer Res. 1980 Nov;40(11):4225-31.
6
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.4'-去甲基表鬼臼毒素9-(4,6-O-2-亚噻吩基-β-D-吡喃葡萄糖苷)(NSC-122819；VM-26)和4'-去甲基表鬼臼毒素9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(NSC-141540；VP-16-213)用于儿童癌症的初步观察
Cancer Chemother Rep. 1975 Jul-Aug;59(4):743-9.
7
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.鬼臼毒素衍生物VP 16 - 213（NSC - 141540）对L1210白血病抗白血病活性的时间依赖性
Acta Pathol Microbiol Scand A. 1973 Sep;81(5):715-24. doi: 10.1111/j.1699-0463.1973.tb03564.x.
8
Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
Cancer Res. 1973 Apr;33(4):791-9.
9
Effect of reserpine (NSC-59272)-induced hypothermia on lifespan in mouse L1210 leukemia.利血平（NSC - 59272）诱导的体温过低对小鼠L1210白血病生存期的影响。
Cancer Chemother Rep. 1974 May-Jun;58(3):317-24.
10
Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.鬼臼毒素衍生物（VM 26和VP 16 - 213）的延迟毒性，由局部效应引起。
Eur J Cancer (1965). 1976 Nov;12(11):925-31. doi: 10.1016/0014-2964(76)90010-4.

引用本文的文献

1
Evaluation of antitumor drug side effects in small animals.小动物抗肿瘤药物副作用的评估。
Cancer Chemother Pharmacol. 1980;4(2):95-101. doi: 10.1007/BF00254029.
2
Absence of delayed lethality in mice treated with aclacinomycin A.阿克拉霉素A治疗的小鼠未出现延迟性致死。
Cancer Chemother Pharmacol. 1981;6(2):161-8. doi: 10.1007/BF00262337.
3
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
Invest New Drugs. 1983;1(2):151-9. doi: 10.1007/BF00172074.
4
Efficacy and toxicity of 4-(2-sulfonatoethylthio)-cyclophosphamide cyclohexylamine salt (ASTA Z 7557, INN mafosfamide) after intraperitoneal administration to mice.4-(2-磺基乙基硫代)-环磷酰胺环己胺盐（ASTA Z 7557，国际非专利药品名称马磷酰胺）腹腔注射给小鼠后的疗效和毒性
Invest New Drugs. 1984;2(2):215-20. doi: 10.1007/BF00232354.
5
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.替尼泊苷耐药L1210细胞中的耐药及交叉耐药表达
Cancer Chemother Pharmacol. 1987;19(2):123-30. doi: 10.1007/BF00254563.